Terms: = Leukemia AND CARS, P49589, 833, ENSG00000110619 AND Diagnosis
16 results:
1. Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study.
Hekmatshoar Y; Rahbar Saadat Y; Ozkan T; Bozkurt S; Karadag Gurel A
Nucleosides Nucleotides Nucleic Acids; 2024; 43(7):664-684. PubMed ID: 38117080
[TBL] [Abstract] [Full Text] [Related]
2. [To compare the efficacy and incidence of severe hematological adverse events of flumatinib and imatinib in patients newly diagnosed with chronic phase chronic myeloid leukemia].
Zhang XS; Liu BC; Du X; Zhang YL; Xu N; Liu XL; Li WM; Lin H; Liang R; Chen CY; Huang J; Yang YF; Zhu HL; Pan L; Wang XD; Li GH; Liu ZG; Zhang YQ; Liu ZF; Hu JD; Liu CS; Li F; Yang W; Meng L; Han YQ; Lin LE; Zhao ZY; Tu CQ; Zheng CF; Bai YL; Zhou ZP; Chen SN; Qiu HY; Yang LJ; Sun XL; Sun H; Zhou L; Liu ZL; Wang DY; Guo JX; Pang LP; Zeng QS; Suo XH; Zhang WH; Zheng YJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2023 Sep; 44(9):728-736. PubMed ID: 38049316
[No Abstract] [Full Text] [Related]
3. Clinical Applications of Flow Cytometry in Cancer Immunotherapies: From diagnosis to Treatments.
Mishra HK
Methods Mol Biol; 2023; 2593():93-112. PubMed ID: 36513926
[TBL] [Abstract] [Full Text] [Related]
4. High CRP-albumin ratio predicts poor prognosis in transplant ineligible elderly patients with newly diagnosed acute myeloid leukemia.
Senjo H; Onozawa M; Hidaka D; Yokoyama S; Yamamoto S; Tsutsumi Y; Haseyama Y; Nagashima T; Mori A; Ota S; Sakai H; Ishihara T; Miyagishima T; Kakinoki Y; Kurosawa M; Kobayashi H; Iwasaki H; Hashimoto D; Kondo T; Teshima T
Sci Rep; 2022 May; 12(1):8885. PubMed ID: 35614177
[TBL] [Abstract] [Full Text] [Related]
5. [cars, CRS and neurotoxicity: severe complications after administration of immunotherapy : Essentials for intensivists].
Prinz J; d'Hargues Y; Gödel P; Shimabukuro-Vornhagen A; Kochanek M; Böll B
Med Klin Intensivmed Notfmed; 2020 Apr; 115(3):198-204. PubMed ID: 30547223
[TBL] [Abstract] [Full Text] [Related]
6. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.
Gibson TM; Mostoufi-Moab S; Stratton KL; Leisenring WM; Barnea D; Chow EJ; Donaldson SS; Howell RM; Hudson MM; Mahajan A; Nathan PC; Ness KK; Sklar CA; Tonorezos ES; Weldon CB; Wells EM; Yasui Y; Armstrong GT; Robison LL; Oeffinger KC
Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
[TBL] [Abstract] [Full Text] [Related]
7. Increased Mortality Among Patients With Acute leukemia Admitted on Weekends Compared to Weekdays.
Parikh K; Shah M; Mehta D; Arora S; Patel N; Liu D
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e33-e43. PubMed ID: 28864171
[TBL] [Abstract] [Full Text] [Related]
8. Mortality risk among workers with exposure to dioxins.
Collins JJ; Bodner KM; Aylward LL; Bender TJ; Anteau S; Wilken M; Bodnar CM
Occup Med (Lond); 2016 Dec; 66(9):706-712. PubMed ID: 27932487
[TBL] [Abstract] [Full Text] [Related]
9. Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study.
Mariette C; Tavernier E; Hocquet D; Huynh A; Isnard F; Legrand F; Lhéritier V; Raffoux E; Dombret H; Ifrah N; Cahn JY; Thiébaut A
Leuk Lymphoma; 2017 Mar; 58(3):586-593. PubMed ID: 27397551
[TBL] [Abstract] [Full Text] [Related]
10. Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-Analysis.
Kourie HR; Ameye L; Paesmans M; Bron D
Clin Lymphoma Myeloma Leuk; 2016 May; 16(5):264-8. PubMed ID: 26935576
[TBL] [Abstract] [Full Text] [Related]
11. Accidental diagnosis: Aeromonas infection leading to discovery of acute myeloid leukemia with meylodysplastic syndrome.
Rausch S
Lab Med; 2014; 45(3):e96-100. PubMed ID: 25118220
[TBL] [Abstract] [Full Text] [Related]
12. The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis.
van der Holt B; Löwenberg B; Burnett AK; Knauf WU; Shepherd J; Piccaluga PP; Ossenkoppele GJ; Verhoef GE; Ferrant A; Crump M; Selleslag D; Theobald M; Fey MF; Vellenga E; Dugan M; Sonneveld P
Blood; 2005 Oct; 106(8):2646-54. PubMed ID: 15994288
[TBL] [Abstract] [Full Text] [Related]
13. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
Montecalvo MA; Jarvis WR; Uman J; Shay DK; Petrullo C; Horowitz HW; Wormser GP
Infect Control Hosp Epidemiol; 2001 Jul; 22(7):437-42. PubMed ID: 11583213
[TBL] [Abstract] [Full Text] [Related]
14. MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia.
van den Heuvel-Eibrink MM; Wiemer EA; de Boevere MJ; van der Holt B; Vossebeld PJ; Pieters R; Sonneveld P
Blood; 2001 Jun; 97(11):3605-11. PubMed ID: 11369657
[TBL] [Abstract] [Full Text] [Related]
15. Pharmacologic approaches to reversing multidrug resistance.
Sikic BI
Semin Hematol; 1997 Oct; 34(4 Suppl 5):40-7. PubMed ID: 9408960
[TBL] [Abstract] [Full Text] [Related]
16. Environmental exposure to gasoline and leukemia in children and young adults--an ecology study.
Nordlinder R; Järvholm B
Int Arch Occup Environ Health; 1997; 70(1):57-60. PubMed ID: 9258708
[TBL] [Abstract] [Full Text] [Related]